Articles

C3.ai expects to incur a sizable earnings loss, so don't assume that AI stock will take a moonshot ride anytime soon. More

With Verrica Pharmaceuticals releasing positive Phase 3 trial results for a skin disease therapeutic, VRCA stock skyrocketed in response. More

Investors wanting to benefit from the continued boom in artificial intelligence should consider these AI stocks to buy. More

Speculative tech stocks are soaring this holiday season. But these three tech stocks to sell aren't worth the gamble. More

As Bitcoin spikes, these three altcoins also seem primed for big gains as this bull market continues to rage on. More

Look for continued gains in these tokens, each of which has enjoyed a big run in the last year. Consider buying these cryptos to get rich. More

Get rich slowly with this trio of high-quality dividend stocks. Their wide moats and cash flow make these top options for dividend investors. More

Subscriber Sign in